Family Care Hospitals Ltd

Family Care Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Family Care Hospitals Ltd

₹ 6.74 -0.15%
22 Nov - close price
scandent.in BSE: 516110
About

Incorporated in 1994, Family Care Hospitals
Ltd is in the business of Healthcare Services[1]

Key Points

Services Offered:[1][2][3]
a) Dental:
Company provides 3D imaging in Cone
Beam Computed Tomography (CBCT),
a useful tool for imaging the craniofacial
area and in 2D Imaging it provides Digital Orthopantomogram (OPG), and Lateral Cephalogram.
b) ENT:
Company offers high quality images
to view the hard tissues within the ear
canal with a wide range of 'Field of View'
(FOV).
c) Radiographic Reports:
All 3D and 2D images are interpreted
and reported by experienced maxillo
facial radiologists of company
d) Family Care Hospitals:
Company has 2 hospitals, one in Mira
Road, Maharashtra and the other at Mahim, Mumbai both of which provide General Surgeries, Plastic Surgeries and treatment in Gynecology, Cardiology, Proctology, Urology, Orthopedics
and ENT.

Website BSE
  • Market Cap ₹ 36.4 Cr.
  • Current Price ₹ 6.74
  • High / Low ₹ 10.3 / 6.23
  • Stock P/E 0.88
  • Book Value ₹ 2.67
  • Dividend Yield 0.00 %
  • ROCE 15.4 %
  • ROE 24.1 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 24.6%

Cons

  • Promoter holding is low: 18.5%
  • Tax rate seems low
  • Promoters have pledged 61.7% of their holding.
  • Company has high debtors of 310 days.
  • Promoter holding has decreased over last 3 years: -32.7%
  • Working capital days have increased from 195 days to 287 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
10 11 8 11 11 11 14 12 12 11 4 4 4
8 9 7 9 9 9 11 10 10 10 3 4 -27
Operating Profit 2 2 2 2 2 2 2 2 2 1 1 0 31
OPM % 21% 19% 23% 18% 19% 18% 16% 19% 16% 13% 23% 6% 798%
0 0 0 0 0 0 0 0 0 1 2 0 -74
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit before tax 2 2 1 2 2 2 2 2 2 2 3 0 -43
Tax % 26% 26% 28% 26% 26% 26% 37% 29% 28% 30% -227% 27% -0%
1 1 1 1 1 1 1 1 1 1 9 0 -43
EPS in Rs 0.17 0.19 0.15 0.18 0.20 0.16 0.24 0.25 0.23 0.21 1.59 0.04 -8.01
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
0 0 0 1 2 5 14 13 35 42 42 40 23
0 0 0 1 2 4 13 11 27 33 34 33 -10
Operating Profit -0 -0 -0 0 0 1 1 2 8 9 8 7 34
OPM % -3,400% -243% 20% 14% 26% 10% 17% 23% 21% 20% 17% 143%
0 0 -25 0 0 0 0 -0 -0 0 1 3 -71
Interest 0 0 0 0 0 0 1 1 1 0 1 1 0
Depreciation 0 0 0 0 0 0 1 1 1 1 1 1 1
Profit before tax 0 -0 -25 0 0 1 0 0 6 7 7 8 -39
Tax % 0% 0% 0% 21% 20% 60% 33% 28% 26% 29% -54%
0 -0 -25 0 0 1 0 0 4 5 5 13 -33
EPS in Rs -3.41 0.00 0.02 0.12 0.00 0.00 0.56 0.71 0.97 2.32 -6.17
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 6% 5% 0%
Compounded Sales Growth
10 Years: 129%
5 Years: 23%
3 Years: 4%
TTM: -52%
Compounded Profit Growth
10 Years: 44%
5 Years: 263%
3 Years: 43%
TTM: 711%
Stock Price CAGR
10 Years: %
5 Years: -5%
3 Years: -27%
1 Year: -29%
Return on Equity
10 Years: 23%
5 Years: 26%
3 Years: 25%
Last Year: 24%

Balance Sheet

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 3 3 32 32 32 32 32 32 32 32 54 54 54
Reserves -3 -3 -28 -28 -28 -27 -27 -27 -23 -18 -8 4 -40
0 0 1 1 0 0 6 10 6 4 4 4 2
0 0 0 0 1 5 3 3 6 21 24 8 35
Total Liabilities 0 0 5 5 6 10 14 17 20 40 75 70 52
0 0 2 2 2 7 9 10 8 7 7 6 5
CWIP 0 0 0 0 1 1 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 3 3 2 2 5 8 12 33 68 64 47
Total Assets 0 0 5 5 6 10 14 17 20 40 75 70 52

Cash Flows

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
0 -0 -0 0 0 3 -4 -1 4 2 -5 -0
0 0 -2 -0 -1 -5 -2 -2 -0 -0 -2 -0
-0 0 5 0 1 0 6 5 -5 -2 26 -1
Net Cash Flow 0 0 3 -0 -0 -2 0 1 -1 -0 19 -2

Ratios

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 0 0 0 0 0 65 113 93 186 252 310
Inventory Days 149 29 4 6 16
Days Payable 977 212 382 387 126
Cash Conversion Cycle 0 0 0 0 0 65 -715 -89 -193 -129 201
Working Capital Days 365 0 31 -251 -312 -146 61 67 119 178 287
ROCE % 0% -2,267% -4% 1% 5% 25% 7% 8% 47% 46% 23% 15%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
51.24% 50.73% 42.39% 13.74% 13.74% 18.54% 18.54% 18.54% 18.54% 18.54% 18.54% 18.54%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.19% 0.00% 0.00% 0.00%
0.15% 0.15% 0.15% 0.14% 0.14% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09%
48.61% 49.12% 57.46% 86.10% 86.11% 81.37% 81.37% 81.38% 81.17% 81.38% 81.37% 81.37%
No. of Shareholders 6,8147,78123,25537,90535,66534,48937,79839,15738,89241,95642,15545,369

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports